The global age-related macular degeneration (AMD) therapeutics market is expected to grow at a favorable rate from 2021 to 2031 (forecast period). The increasing incidence of AMD is a major factor expected to drive the global age-related macular degeneration (AMD) therapeutics market during the forecast period. This is due to the existence of high-risk factors contributing to the onset of the illness. Moreover, aging, high blood pressure, smoking, and high cholesterol are key risk factors for the development of AMD.
Furthermore, wet AMD has an incidence rate of 10% to 15%, while dry AMD has 85-90%. Despite its high incidence, there are no authorized medications for the treatment of dry AMD on the market. The high incidence of dry AMD, combined with a significant unmet medical need, is likely to fuel global age-related macular degeneration (AMD) therapeutics market growth throughout the forecast period.
https://www.transparencymarketresearch.com/amd-therapeutics.html
